BPA Call HT001415A0024-HT001418F0289
Award Date
6/27/18
Potential Completion Date
9/30/18
Potential Value
$250K
Federal Agency
Defense Health Agency
Awardee
The Compounding Center Inc.
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20810, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price contract awarded by the Defense Health Agency (DHA) to The Compounding Center Inc., a minority-owned, self-certified small disadvantaged business. The $300,000 contract provides the DHA with a variety of pharmaceutical products, including blood products, oncology drugs, and other injectable, oral, and inhalation medications to address shortages impacting patient care at military and civilian treatment facilities. The contract is structured as a Blanket Purchase...
This is a firm fixed-price Blanket Purchase Agreement (BPA) call award made by the Defense Health Agency (DHA) to The Compounding Center Inc., a minority-owned, small disadvantaged business. The $400,000 award is for the delivery of specialized pharmaceuticals and compounded medications to address drug shortages impacting patient care at military and civilian treatment facilities. The Compounding Center has received over $700,000 in prior awards from the Department of Health and Human Services...
This is a firm fixed price contract awarded by the Defense Health Agency, a component of the Department of Defense, to The Compounding Center Inc., a minority-owned, self-certified small disadvantaged business, to provide specialized pharmaceutical compounds and medications to address shortages impacting patient care at military and civilian treatment facilities. The $650,000 contract is a blanket purchase agreement (BPA) call that allows for the expedited acquisition of customized drugs and...
This firm fixed price blanket purchase agreement (BPA) call contract was awarded on June 9, 2021 by the Defense Health Agency to provide pharmaceutical supplies in support of agency programs. With a potential value of $25,000, the contract has a completion date of June 6, 2022 and calls off of an existing BPA for these products and services. The Compounding Center Inc. of Bethesda, Maryland will deliver the requested pharmaceutical supplies to locations within that city. No set-aside designation...
This is a firm fixed price contract awarded by the Defense Health Agency to The Compounding Center Inc., a minority-owned and self-certified small disadvantaged business. The $300,000.00 contract is for the delivery of specialized pharmaceuticals and compounded medications to address shortages impacting patient care at military and civilian treatment facilities. The Compounding Center has received over $700,000 in prior awards from the Department of Health and Human Services and Defense Health...
This federal contract award was issued by the Defense Health Agency, a component of the Department of Defense, to The Compounding Center Inc., a minority-owned, self-certified small disadvantaged business. The $400,000 firm fixed price contract is for the delivery of various shortage pharmaceuticals to support patient care at military hospitals and clinics. The contract has no set-aside designation. The Compounding Center Inc. has received over $700,000 in previous contract awards from the...
This is a $150,000 firm fixed-price Blanket Purchase Agreement (BPA) call contract awarded by the Bureau of Medicine and Surgery, a Defense agency, to Broughton Pharmaceuticals, LLC, a for-profit limited liability company. The contract is for the provision of pharmaceutical shortage supplies, including products such as RYDAPT, Novolog insulin, Carimune, and oncological drugs, as well as personal protective equipment (PPE) like N95 masks and disinfectant wipes. This BPA call is part of a larger...
This contract was awarded by the Defense Health Agency (DHA) to TDS Med, Inc., a small disadvantaged business, to provide various pharmaceutical shortage items including blood products, oncological pharmaceuticals, injectables, orals, and medical inhalations. The contract is a Blanket Purchase Agreement (BPA) call with a firm-fixed price and a potential value of $300,000.00. The period of performance runs through September 30, 2018. This BPA is part of a larger $2 million DHA BPA awarded to...
This federal contract award is to Broughton Pharmaceuticals, LLC, a for-profit limited liability company based in Savannah, Georgia. The contract, awarded by the Defense Health Agency (DHA), is a Blanket Purchase Agreement (BPA) with a ceiling value of $2,000,000 that extends through September 24, 2024. Under this BPA, Broughton Pharmaceuticals provides a variety of pharmaceutical products to support the DHA's operations, particularly for the Walter Reed National Military Medical Center in...
The U.S. Defense Health Agency awarded a firm-fixed-price Blanket Purchase Agreement (BPA) call worth up to $300,000 to TDS Med, Inc., a self-certified small disadvantaged business, to provide pharmaceuticals, blood products, and other medical items including injectables, orals, and inhalations. This BPA was established in September 2019 and has a 5-year ordering period. TDS Med, Inc. has previously provided COVID-19 response and pharmaceutical shortage support to the Department of Defense and...